Lv4
564 积分 2025-02-10 加入
The 34th Anual Meeting of the Asian Pacific Association for the study of the liver
16小时前
求助中
Bioactive dietary components—Anti‐obesity effects related to energy metabolism and inflammation
1天前
已完结
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
6天前
已完结
Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care
6天前
已关闭
The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study
6天前
已完结
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
10天前
已完结
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
10天前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
10天前
已完结
Managing early-onset type 2 diabetes in the individual and at the population level
13天前
已完结
Understanding the drivers and consequences of early-onset type 2 diabetes
13天前
已完结
皖公网安备34019202002308
